CBO: Key to Innovation is Making it a National Priority
By Mari Serebrov
Thursday, April 25, 2013
To spur innovation in biopharma and other industries, Congress must make it a national priority, according to the Congressional Budget Office (CBO).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.